Arcturus Therapeutics Holdings Inc. Quarterly Current Ratio in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Arcturus Therapeutics Holdings Inc. quarterly Current Ratio history and growth rate from Q1 2020 to Q3 2024.
  • Arcturus Therapeutics Holdings Inc. Current Ratio for the quarter ending September 30, 2024 was 402 %, a 1.21% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 402 -4.92 -1.21% Sep 30, 2024
Q2 2024 399 +17.9 +4.71% Jun 30, 2024
Q1 2024 410 +56.2 +15.9% Mar 31, 2024
Q4 2023 454 +139 +44.2% Dec 31, 2023
Q3 2023 407 +75.2 +22.7% Sep 30, 2023
Q2 2023 381 +41.4 +12.2% Jun 30, 2023
Q1 2023 354 -41.2 -10.4% Mar 31, 2023
Q4 2022 315 -185 -37% Dec 31, 2022
Q3 2022 331 -284 -46.2% Sep 30, 2022
Q2 2022 339 -499 -59.5% Jun 30, 2022
Q1 2022 395 -510 -56.3% Mar 31, 2022
Q4 2021 500 -308 -38.2% Dec 31, 2021
Q3 2021 616 -16.2 -2.57% Sep 30, 2021
Q2 2021 838 +428 +104% Jun 30, 2021
Q1 2021 906 +559 +161% Mar 31, 2021
Q4 2020 808 Dec 31, 2020
Q3 2020 632 Sep 30, 2020
Q2 2020 410 Jun 30, 2020
Q1 2020 346 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.